Moderna vaccine appears to be safe for adolescents, according to recent trials

Moderna’s vaccine appears to be safe in adolescents, according to the company.

In a phase 2/3 trial of 3732 children ages 12 to 17 in the United States, blood tests showed that an immune response was produced by the vaccine on the same level seen in adults. The trial didn’t specifically look at the efficacy of the vaccine, but it was noted that no child contracted the virus starting 14 days after the second dose. The company says that figures can still shift as more data is gathered. The tests showed the vaccine to be 93 percent effective at preventing mild doses of COVID after one dose. Moderna announced the results Tuesday in a news release, and the results have not yet been peer reviewed or published.

The company said they did not find any significant safety concerns. Side effects included headache, fatigue, muscle pain and chills after administration of the second dose. Pain at the injection site was also sometimes observed. Moderna plans to submit their findings and a request for authorization to the U.S. Food and Drug Administration in early June. Currently, Pfizer’s COVID-19 vaccine is the only one to have gained emergency use authorization from the FDA to include 12- to 15-year-olds.

READ MORE UNBIASED NEWS AT FBANEWS.ORG

ARTICLE: DUSTIN RODGERS

POLITICS EDITOR: CARSON CHOATE

PHOTO CREDITS: WALL STREET JOURNAL

The following two tabs change content below.

• Bio
• Latest Posts

Carson Choate

Latest posts by Carson Choate (see all)

• Rep. Kinzinger urges DOJ to ‘do the right thing’ by charging Trump for Capitol riot - January 3, 2023
• New Yorker publishes ‘case for wearing masks forever’ from group who wants stricter COVID restrictions - January 3, 2023
• Survey: One-third of Americans think Christians should compromise their beliefs to align with ‘liberal ideology’ - December 27, 2022